Brief: Vimta Labs Enters Into Business Transfer Agreement With Thyrocare Technologies
Aug 30 (Reuters) - Vimta Labs Ltd VIML.NS :
* ENTERED INTO BUSINESS TRANSFER AGREEMENT WITH THYROCARE
TECHNOLOGIES
* TO SELL ITS DIAGNOSTICS, PATHOLOGICAL SERVICES BUSINESS TO
THYROCARE
* DEAL FOR 70 MILLION RUPEES
Source text for Eikon: ID:nBSE9YlpNx
Further company coverage: THYO.NS
(Reporting by VijayDattaram Malkar)
((VijayDattaram.Malkar@thomsonreuters.com;))
Recent news on Vimta Labs
See all newsBrief: Vimta Labs June-Quarter Profit 210.4 Million Rupees
Brief: Vimta Labs Recommends Dividend Of 2 Rupees Per Share
Brief: Vimta Labs March-Quarter Profit From Continuing Operations 211.1 Million Rupees
India's Vimta Labs climbs on Q4 profit rise, bonus issue
Brief: Vimta Labs Recommends Dividend Of 2 Rupees Per Share